Cubist Systematic Strategies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,452
| Closed | -$60K | – | 4045 |
|
|
2021
Q4 | $60K | Sell |
19,452
-1,795
| -8% | -$6.04K | ﹤0.01% | 3287 |
|
|
2021
Q3 | $77K | Buy |
21,247
+1,697
| +9% | +$6.4K | ﹤0.01% | 2788 |
|
|
2021
Q2 | $70K | Sell |
19,550
-41,350
| -68% | -$146K | ﹤0.01% | 2757 |
|
|
2021
Q1 | $238K | Sell |
60,900
-5,967
| -9% | -$24.6K | ﹤0.01% | 2375 |
|
|
2020
Q4 | $281K | Sell |
66,867
-31,283
| -32% | -$121K | ﹤0.01% | 2072 |
|
|
2020
Q3 | $366K | Buy |
98,150
+18,950
| +24% | +$80.6K | 0.01% | 1912 |
|
|
2020
Q2 | $345K | Buy |
79,200
+30,412
| +62% | +$137K | 0.01% | 1790 |
|
|
2020
Q1 | $185K | Sell |
48,788
-162,656
| -77% | -$799K | 0.01% | 1764 |
|
|
2019
Q4 | $1.34M | Buy |
211,444
+188,941
| +840% | +$1.11M | 0.02% | 978 |
|
|
2019
Q3 | $95K | Sell |
22,503
-75,146
| -77% | -$321K | ﹤0.01% | 1947 |
|
|
2019
Q2 | $454K | Sell |
97,649
-24,362
| -20% | -$113K | 0.01% | 1540 |
|
|
2019
Q1 | $647K | Buy |
122,011
+116,181
| +1,993% | +$531K | 0.02% | 1020 |
|
|
2018
Q4 | $22K | Sell |
5,830
-5,912
| -50% | -$20.8K | ﹤0.01% | 1944 |
|
|
2018
Q3 | $33K | Buy |
+11,742
| New | +$33K | ﹤0.01% | 1760 |
|
|
2015
Q4 | – | Sell |
-41,900
| Closed | -$233K | – | 2178 |
|
|
2015
Q3 | $233K | Buy |
41,900
+22,438
| +115% | +$166K | 0.01% | 1387 |
|
|
2015
Q2 | $155K | Buy |
19,462
+18,389
| +1,714% | +$158K | 0.01% | 1530 |
|
|
2015
Q1 | $11K | Sell |
1,073
-21,820
| -95% | -$298K | ﹤0.01% | 1834 |
|
|
2014
Q4 | $275K | Buy |
+22,893
| New | +$348K | 0.01% | 1289 |
|
Other funds holding BDSI
Cubist Systematic Strategies's BDSI Position: Q1 2022 in Review
Cubist Systematic Strategies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 19,452 shares — an estimated $60K sold.
Cubist Systematic Strategies first reported a position in BDSI in Q4 2014 and held it in 18 quarters. The position peaked at $1.34M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Cubist Systematic Strategies reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 19,452 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $60K.
- Cubist Systematic Strategies first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 18 quarters.
- Cubist Systematic Strategies's BioDelivery Sciences International, Inc. position peaked at $1.34M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.